Waters Co. (NYSE:WAT) Shares Sold by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. decreased its stake in shares of Waters Co. (NYSE:WATFree Report) by 89.9% during the first quarter, HoldingsChannel reports. The firm owned 2,825 shares of the medical instruments supplier’s stock after selling 25,238 shares during the quarter. Assenagon Asset Management S.A.’s holdings in Waters were worth $972,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in WAT. Vanguard Group Inc. increased its stake in shares of Waters by 1.0% in the fourth quarter. Vanguard Group Inc. now owns 6,837,662 shares of the medical instruments supplier’s stock worth $2,251,163,000 after acquiring an additional 64,525 shares during the period. GUARDCAP ASSET MANAGEMENT Ltd purchased a new stake in shares of Waters in the fourth quarter worth about $361,839,000. Invesco Ltd. grew its holdings in Waters by 3.0% during the third quarter. Invesco Ltd. now owns 1,092,459 shares of the medical instruments supplier’s stock worth $299,563,000 after acquiring an additional 32,059 shares during the period. Nordea Investment Management AB raised its position in Waters by 129.9% during the fourth quarter. Nordea Investment Management AB now owns 973,537 shares of the medical instruments supplier’s stock valued at $322,017,000 after acquiring an additional 550,112 shares in the last quarter. Finally, American Century Companies Inc. lifted its holdings in Waters by 34.3% in the third quarter. American Century Companies Inc. now owns 832,895 shares of the medical instruments supplier’s stock valued at $228,388,000 after acquiring an additional 212,754 shares during the period. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Insider Buying and Selling

In other Waters news, Director Christopher A. Kuebler sold 4,000 shares of the firm’s stock in a transaction that occurred on Wednesday, May 15th. The shares were sold at an average price of $361.64, for a total value of $1,446,560.00. Following the transaction, the director now directly owns 14,716 shares of the company’s stock, valued at approximately $5,321,894.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, Director Christopher A. Kuebler sold 4,000 shares of the stock in a transaction on Wednesday, May 15th. The stock was sold at an average price of $361.64, for a total transaction of $1,446,560.00. Following the completion of the transaction, the director now directly owns 14,716 shares in the company, valued at approximately $5,321,894.24. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Linda Baddour sold 500 shares of the business’s stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $355.54, for a total transaction of $177,770.00. Following the completion of the sale, the director now owns 2,250 shares in the company, valued at $799,965. The disclosure for this sale can be found here. 0.82% of the stock is currently owned by company insiders.

Waters Price Performance

Shares of Waters stock traded down $2.37 during mid-day trading on Tuesday, reaching $351.65. 361,073 shares of the stock traded hands, compared to its average volume of 422,333. The stock has a market capitalization of $20.86 billion, a PE ratio of 34.51, a PEG ratio of 5.66 and a beta of 0.98. The business has a 50-day moving average of $333.61 and a 200 day moving average of $318.11. Waters Co. has a fifty-two week low of $231.90 and a fifty-two week high of $367.21. The company has a quick ratio of 1.30, a current ratio of 1.94 and a debt-to-equity ratio of 1.60.

Waters (NYSE:WATGet Free Report) last posted its quarterly earnings data on Tuesday, May 7th. The medical instruments supplier reported $2.21 EPS for the quarter, beating the consensus estimate of $2.10 by $0.11. Waters had a return on equity of 66.59% and a net margin of 20.75%. The firm had revenue of $636.80 million during the quarter, compared to the consensus estimate of $635.57 million. During the same period in the prior year, the company earned $2.49 EPS. The firm’s revenue was down 7.0% compared to the same quarter last year. On average, analysts predict that Waters Co. will post 11.86 EPS for the current year.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the stock. Stifel Nicolaus raised their price objective on shares of Waters from $330.00 to $332.00 and gave the stock a “hold” rating in a research note on Wednesday, May 8th. TD Cowen raised their price target on shares of Waters from $350.00 to $358.00 and gave the company a “hold” rating in a research report on Wednesday, May 8th. Barclays decreased their price objective on shares of Waters from $300.00 to $295.00 and set an “underweight” rating for the company in a research report on Wednesday, May 8th. Evercore ISI raised their target price on Waters from $320.00 to $340.00 and gave the company an “in-line” rating in a research report on Thursday, April 4th. Finally, Robert W. Baird reduced their price target on Waters from $319.00 to $312.00 and set a “neutral” rating for the company in a report on Wednesday, May 8th. One analyst has rated the stock with a sell rating and ten have given a hold rating to the company’s stock. Based on data from MarketBeat, Waters presently has an average rating of “Hold” and a consensus price target of $305.78.

Check Out Our Latest Stock Analysis on WAT

Waters Profile

(Free Report)

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Featured Stories

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WATFree Report).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.